Blood and lymphatic systems are segregated by the FLCN tumor suppressor
2020 · Nature Communications · 23 citations
https://doi.org/10.1038/s41467-020-20156-6
C
Chang Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
152
Citations
7
h-index
5
i10-index
Chang Liu is an academic researcher from Peking University. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment. The author has an h-index of 7, co-authored 11 publications.
ORCID: 0000-0003-1909-8186Papers by this author
worksMalignant transformation of hepatic endometriosis: a case report and literature review
2021 · BMC Women s Health · 13 citations
https://doi.org/10.1186/s12905-021-01366-6
MiR-155, a potential serum marker of extramammary Paget’s disease
2018 · BMC Cancer · 11 citations
https://doi.org/10.1186/s12885-018-4994-1
Natto consumption suppresses atherosclerotic plaque progression in LDL receptor-deficient mice transplanted with iRFP-expressing hematopoietic cells
2023 · Scientific Reports · 8 citations
https://doi.org/10.1038/s41598-023-48562-y
Accuracy of ultrasound-guided fine-needle aspiration for small cervical lymph nodes: A retrospective review of 505 cases
2024 · Heliyon · 4 citations
https://doi.org/10.1016/j.heliyon.2024.e31238
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat